Medical Health & Life Science Research News

Research delivers insight into the RSV diagnostics market worth 929.2 million USD by 2022

Medical Market Research

According to a new market research "RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) - Global Forecast to 2022" published by MarketsandMarkets™, the market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%.

- Advertising -

Browse 86 tables and 31 figures spread through 113 pages and in-depth TOC on "RSV Diagnostics Market"

www.marketsandmarkets.com/Market-R…ket-95683942.html

Early buyers will receive 10% customization on this report 

Factors driving the growth of this market include rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays.

Kits and assays are estimated to account for the largest share of the RSV Diagnostics Market in 2017. 

The products segment is further segmented into kits and assays, instruments, and other products. The kits and assays segment is expected to account for the largest share of the global RSV Diagnostics Market in 2017.

- Advertising -

Factors driving the growth of this segment include the increasing infection of RSV in newborn infants and young children and growing demand for kits and assays for RSV diagnosis.

Inquiry Report @  www.marketsandmarkets.com/Enquiry_…mpaign=prnewswire

The molecular diagnostics segment is expected to account for the largest share of the global RSV Diagnostics Marketin 2017. 

The molecular diagnostic segment is expected to account for the largest share of the global RSV Diagnostics Market in 2017. Market growth can largely be attributed to factors such as the increasing adoption and demand for molecular diagnostic testing for RSV diagnosis.

North America is estimated to command the largest share of the market during the forecast period. 

Based on region, the RSV Diagnostics Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the RSV Diagnostics Market in 2017.

This is mainly due to factors such as the increasing patient base of RSV diseases, technological advancements in PoC molecular diagnostic devices, and growing healthcare expenditures.

Download PDF Brochure@ www.marketsandmarkets.com/pdfdownl…mpaign=prnewswire

Key players in the RSV Diagnostics Market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
This email address is being protected from spambots. You need JavaScript enabled to view it.